Secant develops new 3D biomedical technology

Secant uses the company's patented bioelastomer Regenerez to contribute in enhancing the biomechanical properties of the 3D structures by combining the spatial resolution capability with advanced bioresorbable polymers. The new technology transmutes a synthetic textile into an elastomeric scaffold allowing the researchers a broad range of bioresorbable polymers for the structural design, according to a company press release.

“Our 3D biomedical textile engineering technology offers a potential solution to help our customers' resolve the complex challenges of biocompatibility, design and construction, and material properties,” said Jeff Robertson, president, Secant Medical. “Our company was built on innovation and this is just another example of the expertise we can provide to our customers,” he further added.

While 3D printing or additive manufacturing is known as a novel method to create 3D biomedical forms, it does not always offer the dimensional stability, material selection and desired engineering properties.

The company has initiated the developments of an anatomical scaffold prototype based on the trachea. The patent pending technology can provide the researcher with off-the-shelf scaffolds for a range of structures in various sizes to meet demographic demands. The new 3D technology can produce high quality, mass engineered structures with a high degree of repeatability once programmed. (NA)

Fibre2fashion News Desk - India